Page last updated: 2024-08-26

6'-o-methylguanosine and Neurodegenerative Diseases

6'-o-methylguanosine has been researched along with Neurodegenerative Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bammler, TK; Beyer, RP; Churchwell, M; Doerge, DR; Fry, RC; Kavanagh, TJ; Kisby, GE; Lasarev, MR; Meira, LB; Palmer, VS; Ramos-Crawford, AL; Ren, X; Samson, LD; Spencer, PS; Sullivan, RC; Zarbl, H1

Other Studies

1 other study(ies) available for 6'-o-methylguanosine and Neurodegenerative Diseases

ArticleYear
The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner.
    PloS one, 2011, Volume: 6, Issue:6

    Topics: Animals; Binding Sites; Brain; Brain Neoplasms; Cycadopsida; DNA Damage; DNA Modification Methylases; DNA Repair Enzymes; Gene Expression Profiling; Gene Regulatory Networks; Guanosine; Humans; Liver; Male; Methylazoxymethanol Acetate; Mice; Mice, Inbred C57BL; Models, Biological; Mutagens; Neurodegenerative Diseases; Organ Specificity; Signal Transduction; Transcription Factors; Transcription, Genetic; Tumor Suppressor Proteins

2011